Browsing: Reform

Psychedelic legislation is moving through more state capitols simultaneously than at any point in history. The question is not whether reform is coming. It is whether…

Sara Carter, the former investigative journalist and Fox News contributor now serving as White House drug czar, has spent her early months emphasizing fentanyl, trafficking and…

More than a decade ago, my fitness coach and friend, Jenny, called me in distress. She had just been attacked and severely beaten by her ex-boyfriend,…

Guest Op-Ed by Gretchen Gailey, President of Project Champion If there is one lesson the cannabis industry should have learned by now, it’s this: Washington does…

President Donald Trump publicly acknowledged on Monday that his administration is actively considering reclassifying cannabis under federal law, saying the current Schedule I status blocks medical…

Trump is reportedly weighing a directive that would push federal agencies to move cannabis from Schedule I to Schedule III, but the White House says no…

“The only clearly understood consequence of moving cannabis to Schedule III is ending the unfair, excessive tax burden, providing a financial benefit for all marijuana companies…

After months of silence and bureaucratic stalling, the DEA finally has a new boss: Terrance Cole, confirmed by the Senate earlier this week. That might not…

Twenty-six companies spent over $1.6 million on lobbying in Pennsylvania for cannabis reforms last year, according to a Spotlight PA analysis, with over $800,000 coming from…

As the U.S. cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse…